Procoagulant profile in patients with immune thrombocytopenia

British Journal of Haematology

Volumn 175, Issue 5, 2016, Pages 925-934

  Álvarez Román, María T ^a   Fernández Bello, Ihosvany ^a   Jiménez Yuste, Víctor ^a,b   Martín Salces, Mónica ^a   Arias Salgado, Elena G ^c   Rivas Pollmar, María I ^a   Justo Sanz, Raúl ^a   Butta, Nora V ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Madrid River Project   (Spain)

Author keywords

fibrinolysis; immune thrombocytopenia; microparticles; thrombin generation; thromboelastometry

Indexed keywords

DEXAMETHASONE; ELTROMBOPAG; IMMUNOGLOBULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISONE; PROTEIN C; ROMIPLOSTIM; THROMBIN;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RED CELL MICROPARTICLE; ROTATIONAL THROMBOELASTOMETRY; THROMBOCYTE COUNT; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; AGED; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING TEST; COMPLICATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; THROMBOCYTE;

ADULT; AGED; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBELASTOGRAPHY;

EID: 84995503450     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14412     Document Type: Article

References (44)

1. Alvarez Roman, M.T., Fernandez Bello, I., Arias-Salgado, E.G., Rivas Pollmar, M.I., Jimenez Yuste, V., Martin Salces, M. & Butta, N.V. (2014) Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia. Thrombosis and Haemostasis, 112, 65–72.
2. Ando, M., Iwata, A., Ozeki, Y., Tsuchiya, K., Akiba, T. & Nihei, H. (2002) Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney International, 62, 1757–1763.
3. Arnout, J. (2001) Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants. Thrombosis and Haemostasis, 86, 83–91.
4. Cheng, G., Saleh, M.N., Marcher, C., Vasey, S., Mayer, B., Aivado, M., Arning, M., Stone, N.L. & Bussel, J.B. (2011) Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet, 377, 393–402.
5. Cines, D.B., Bussel, J.B., Liebman, H.A. & Luning Prak, E.T. (2009) The ITP syndrome: pathogenic and clinical diversity. Blood, 113, 6511–6521.
6. Connor, D.E., Ma, D.D. & Joseph, J.E. (2013) Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders. Thrombosis Research, 132, 572–577.
7. Devreese, K., Peerlinck, K., Arnout, J. & Hoylaerts, M.F. (2009) Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thrombosis and Haemostasis, 101, 185–196.
8. Doobaree, I.U., Nandigam, R., Bennett, D., Newland, A. & Provan, D. (2016) Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis. European Journal of Haematology, 97, 321–330.
9. Fogarty, P.F., Tarantino, M.D., Brainsky, A., Signorovitch, J. & Grotzinger, K.M. (2012) Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia. Current Medical Research and Opinion, 28, 79–87.
10. Fruchter, O., Blich, M. & Jacob, G. (2002) Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura. American Journal of the Medical Sciences, 323, 279–280.
11. Giltay, J.C., Brinkman, H.J., Modderman, P.W., von dem Borne, A.E. & van Mourik, J.A. (1989) Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood, 73, 1235–1241.
12. Goubran, H., Sabry, W., Kotb, R., Seghatchian, J. & Burnouf, T. (2015) Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci, 53, 168–172.
13. Gunduz, E., Akay, O.M., Bal, C. & Gulbas, Z. (2011) Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura? Platelets, 22, 516–520.
14. Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 4–15.
15. Herault, J.P., Dol, F., Gaich, C., Bernat, A. & Herbert, J.M. (1999) Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thrombosis and Haemostasis, 81, 957–960.
16. Huerta, C., Johansson, S., Wallander, M.A. & Garcia Rodriguez, L.A. (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Archives of Internal Medicine, 167, 935–943.
17. Jy, W., Horstman, L.L., Arce, M. & Ahn, Y.S. (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. Journal of Laboratory and Clinical Medicine, 119, 334–345.
18. Jy, W., Johansen, M.E., Bidot, Jr, C., Horstman, L.L. & Ahn, Y.S. (2013) Red cell-derived microparticles (RMP) as haemostatic agent. Thrombosis and Haemostasis, 110, 751–760.
19. Kim, W.H., Park, J.B., Jung, C.W. & Kim, G.S. (2015) Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura. Platelets, 26, 38–42.
20. Kuter, D.J., Rummel, M., Boccia, R., Macik, B.G., Pabinger, I., Selleslag, D., Rodeghiero, F., Chong, B.H., Wang, X. & Berger, D.P. (2010) Romiplostim or standard of care in patients with immune thrombocytopenia. New England Journal of Medicine, 363, 1889–1899.
21. Lakshmanan, S. & Cuker, A. (2012) Contemporary management of primary immune thrombocytopenia in adults. Journal of Thrombosis and Haemostasis, 10, 1988–1998.
22. Majka, M., Kijowski, J., Lesko, E., Gozdizk, J., Zupanska, B. & Ratajczak, M.Z. (2007) Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD34+ hematopoietic stem/progenitor cells – implication for the pathogenesis of immune thrombocytopenias. Folia Histochemica et Cytobiologica, 45, 27–32.
23. Marie, I., Maurey, G., Herve, F., Hellot, M.F. & Levesque, H. (2006) Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. British Journal of Dermatology, 155, 714–721.
24. van der Meijden, P.E., Van Schilfgaarde, M., Van Oerle, R., Renne, T., ten Cate, H. & Spronk, H.M. (2012a) Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. Journal of Thrombosis and Haemostasis, 10, 1355–1362.
25. van der Meijden, P.E., Feijge, M.A., Swieringa, F., Gilio, K., Nergiz-Unal, R., Hamulyak, K. & Heemskerk, J.W. (2012b) Key role of integrin alpha(IIb)beta (3) signaling to Syk kinase in tissue factor-induced thrombin generation. Cellular and Molecular Life Sciences, 69, 3481–3492.
26. Norgaard, M. (2012) Thrombosis in patients with primary chronic immune thrombocytopenia. Thrombosis Research, 130, S74–S75.
27. Norgaard, M., Cetin, K., Maegbaek, M.L., Kristensen, N.R., Ghanima, W., Bahmanyar, S., Stryker, S. & Christiansen, C.F. (2016) Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study. British Journal of Haematology, 174, 639–642.
28. Ostrowski, S.R., Haase, N., Muller, R.B., Moller, M.H., Pott, F.C., Perner, A. & Johansson, P.I. (2015) Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Critical Care, 19, 191.
29. Pierrot-Deseilligny Despujol, C., Michel, M., Khellaf, M., Gouault, M., Intrator, L., Bierling, P. & Godeau, B. (2008) Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. British Journal of Haematology, 142, 638–643.
30. Provan, D., Stasi, R., Newland, A.C., Blanchette, V.S., Bolton-Maggs, P., Bussel, J.B., Chong, B.H., Cines, D.B., Gernsheimer, T.B., Godeau, B., Grainger, J., Greer, I., Hunt, B.J., Imbach, P.A., Lyons, G., McMillan, R., Rodeghiero, F., Sanz, M.A., Tarantino, M., Watson, S., Young, J. & Kuter, D.J. (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood, 115, 168–186.
31. Psaila, B., Bussel, J.B., Linden, M.D., Babula, B., Li, Y., Barnard, M.R., Tate, C., Mathur, K., Frelinger, A.L. & Michelson, A.D. (2012) In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation. Blood, 119, 4066–4072.
32. Qiao, J., Liu, Y., Li, D., Wu, Y., Li, X., Yao, Y., Niu, M., Fu, C., Li, H., Ma, P., Li, Z., Xu, K. & Zeng, L. (2016) Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia. Immunologic Research, 64, 604–609.
33. Reverter, J.C., Beguin, S., Kessels, H., Kumar, R., Hemker, H.C. & Coller, B.S. (1996) Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and “clinical restenosis”. Journal of Clinical Investigation, 98, 863–874.
34. Rodeghiero, F. (2016) Is ITP a thrombophilic disorder? American Journal of Hematology, 91, 39–45.
35. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kuhne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 2386–2393.
36. Rodeghiero, F., Michel, M., Gernsheimer, T., Ruggeri, M., Blanchette, V., Bussel, J.B., Cines, D.B., Cooper, N., Godeau, B., Greinacher, A., Imbach, P., Khellaf, M., Klaassen, R.J., Kuhne, T., Liebman, H., Mazzucconi, M.G., Newland, A., Pabinger, I., Tosetto, A. & Stasi, R. (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood, 121, 2596–2606.
37. Sarpatwari, A., Bennett, D., Logie, J.W., Shukla, A., Beach, K.J., Newland, A.C., Sanderson, S. & Provan, D. (2010) Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica, 95, 1167–1175.
38. Severinsen, M.T., Engebjerg, M.C., Farkas, D.K., Jensen, A.O., Norgaard, M., Zhao, S. & Sorensen, H.T. (2011) Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study. British Journal of Haematology, 152, 360–362.
39. Sewify, E.M., Sayed, D., Abdel Aal, R.F., Ahmad, H.M. & Abdou, M.A. (2013) Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura. Thrombosis Research, 131, e59–e63.
40. Stasi, R., Stipa, E., Masi, M., Oliva, F., Sciarra, A., Perrotti, A., Olivieri, M., Zaccari, G., Gandolfo, G.M., Galli, M., Barbui, T. & Papa, G. (1994) Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood, 84, 4203–4208.
41. Thiagarajan, P., Shapiro, S.S., Levine, E., DeMarco, L. & Yalcin, A. (1985) A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells. Journal of Clinical Investigation, 75, 896–901.
42. Trelinski, J., Misiewicz, M., Robak, M., Smolewski, P. & Chojnowski, K. (2014) Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis. Thrombosis Research, 133, 667–670.
43. Zubairova, L.D., Nabiullina, R.M., Nagaswami, C., Zuev, Y.F., Mustafin, I.G., Litvinov, R.I. & Weisel, J.W. (2015) Circulating microparticles alter formation, structure, and properties of fibrin clots. Scientific Reports, 5, 17611.
44. Zucker-Franklin, D. & Karpatkin, S. (1977) Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. New England Journal of Medicine, 297, 517–523.